Literature DB >> 15700156

[Therapeutic benefits in dermatological therapy. Evaluation of therapy from the physician's und patient's perspective in psoriasis and atopic dermatitis].

I Zschocke1, U Hammelmann, M Augustin.   

Abstract

BACKGROUND: The patient's opinion has received only little consideration in current health-political discussions so far. This study examines the question of agreement between physicians and patients regarding their expectations of therapy and evaluation of its' usefulness. PATIENTS AND METHODS: 133 patients with psoriasis vulgaris (n=73) or atopic dermatitis (n=60) as well as medical personnel (n= 119) were assessed concerning the priority of therapy goals by means of a specially-designed questionnaire.
RESULTS: There was overall agreement on the definition of therapy goals in the improvement of clinical symptoms and the importance of side effects between medical personnel and patients. Psychological distress and social improvements were clearly overrated by the medical staff, whereas the need for less therapeutic expenditure was clearly underestimated.
CONCLUSIONS: The conventional evaluation of drugs and therapies covers the effectiveness and the side effects, topics about which patients and physicians are in general accordance. As far as further evaluation criteria are concerned, discussions should reflect the patient's opinion's, since it cannot be assumed that their perspective is adequately represented by physicians.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15700156     DOI: 10.1007/s00105-005-0898-5

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  8 in total

1.  [Recording of quality of life in dermatological studies. Guidelines of the Subcommission "Pharmacoeconomics and Quality of Life"].

Authors:  M Augustin
Journal:  Hautarzt       Date:  2001-08       Impact factor: 0.751

2.  Psoriasis causes as much disability as other major medical diseases.

Authors:  S R Rapp; S R Feldman; M L Exum; A B Fleischer; D M Reboussin
Journal:  J Am Acad Dermatol       Date:  1999-09       Impact factor: 11.527

3.  Two considerations for patients with psoriasis and their clinicians: what defines mild, moderate, and severe psoriasis? What constitutes a clinically significant improvement when treating psoriasis?

Authors:  G G Krueger; S R Feldman; C Camisa; M Duvic; J T Elder; A B Gottlieb; J Koo; J G Krueger; M Lebwohl; N Lowe; A Menter; W L Morison; J H Prystowsky; J L Shupack; J R Taylor; G D Weinstein; T L Barton; T Rolstad; R M Day
Journal:  J Am Acad Dermatol       Date:  2000-08       Impact factor: 11.527

4.  The development and application of indices of health: general methods and a summary of results.

Authors:  D L Sackett; L W Chambers; A S MacPherson; C H Goldsmith; R G Mcauley
Journal:  Am J Public Health       Date:  1977-05       Impact factor: 9.308

5.  Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use.

Authors:  A Y Finlay; G K Khan
Journal:  Clin Exp Dermatol       Date:  1994-05       Impact factor: 3.470

6.  Patient compliance and disease management in the treatment of psoriasis in the Netherlands.

Authors:  P C van de Kerkhof; D de Hoop; J de Korte; S A Cobelens; M V Kuipers
Journal:  Dermatology       Date:  2000       Impact factor: 5.366

7.  Patient and physician perspectives vary on atopic dermatitis.

Authors:  Robert O McAlister; Susan J Tofte; Joseph J Doyle; Archi Jackson; Jon M Hanifin
Journal:  Cutis       Date:  2002-06

Review 8.  The outcomes movement and new measures of the severity of psoriasis.

Authors:  K E Mckenna; R S Stern
Journal:  J Am Acad Dermatol       Date:  1996-03       Impact factor: 11.527

  8 in total
  2 in total

1.  [Health services research the example of atopic dermatitis].

Authors:  J Schmitt
Journal:  Hautarzt       Date:  2011-03       Impact factor: 0.751

2.  How important is subjective well-being for patients? A qualitative interview study of people with psoriasis.

Authors:  Antonia-Luise Newi; Athanasios Tsianakas; Sophia von Martial; Rachel Sommer; Christine Blome
Journal:  Qual Life Res       Date:  2022-08-10       Impact factor: 3.440

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.